This settlement is closed!
Please see what other class action settlements you might qualify to claim cash from in our Open Settlements directory!
Updates:
- Top Class Actions readers reported this settlement paying out up to $245.32 as of April 2024.
- Congratulations to everyone who filed a claim and got paid!
- The court granted this settlement final approval on Feb. 6, 2024.
- Let Top Class Actions know when you receive a check in the comments section below or on our Settlements & Payouts Facebook group.
Theranos and Walgreens agreed to pay a combined $45.33 million settlement to resolve a class action lawsuit claiming that Theranos blood-testing services were misleadingly advertised.
The settlement benefits consumers who purchased Theranos testing services between November 2013 and June 2016, regardless of whether they paid for these services out of pocket, through health insurance or through any other source.
In addition to the national class, the settlement benefits two statewide subclasses: an Arizona subclass of class members who made Theranos purchases in Arizona between November 2013 and June 2016 and a California subclass of class members who made Theranos purchases in California between September 2013 and June 2016.
The settlement also benefits a Walgreens Edison subclass of Theranos purchasers who were subjected to “tiny” blood draws or fingerpricks by a Walgreens employee between November 2013 and March 2015.
According to the class action lawsuit, Theranos and Walgreens conspired to defraud customers by making them believe they could have sophisticated blood tests done through only a “tiny” blood draw. Plaintiffs in the case claim that they gave blood at Theranos and Walgreens stores under false pretenses since they did not know the tests were unreliable and not market-ready.
Theranos was a consumer healthcare tech startup company valued at $10 billion at its peak — before its founders were charged with fraud by state and federal authorities. Walgreens invested millions of dollars into a partnership with Theranos.
Walgreens agreed to pay $44 million to resolve the testing class action lawsuit. Theranos, which is now dissolved, agreed to contribute $1.33 million to the settlement fund.
Under the terms of the settlement, all class members can receive a base payment of $10 in addition to up to two times the total costs of their Theranos blood testing services, less any payments already received through the Arizona attorney general’s 2017 consent decree.
Walgreens Edison subclass members can receive an additional payment as compensation for battery and medical battery. These payments are estimated to be between $700 and $1,000 per subclass member.
The deadline for exclusion and objection is Jan. 8, 2024.
The final approval hearing for the Walgreens and Theranos class action lawsuit settlement is scheduled for Feb. 6, 2024.
No claim form is required to receive settlement payments. Class members who do not exclude themselves will automatically receive a settlement payment but can update their address on the settlement website.
Who’s Eligible
Consumers who purchased Theranos testing services between November 2013 and June 2016, regardless of whether they paid for these services out of pocket, through health insurance or through any other source.
Two statewide subclasses: an Arizona subclass of class members who made Theranos purchases in Arizona between November 2013 and June 2016 and a California subclass of class members who made Theranos purchases in California between September 2013 and June 2016.
Walgreens Edison subclass: Theranos purchasers who were subjected to “tiny” blood draws or fingerpricks by a Walgreens employee between November 2013 and March 2015.
Potential Award
Varies
Proof of Purchase
N/A
Exclusion Deadline
01/08/2024
Case Name
In re: Arizona Theranos Inc. Litigation, Case No. 2:16-cv-2138- DGC, in the U.S. District Court for the District of Arizona
Final Hearing
02/06/2024
Settlement Website
Claims Administrator
In re: Arizona Theranos Inc. Litigation
c/o JND Legal Administration
PO Box 91214
Seattle, WA 98111
info@TheranosLawsuit.com
866-615-0978
Class Counsel
Mark D Samson
Ron Kilgard
Alison E Chase
KELLER ROHRBACK LLP
Michael W Sobol
Roger N Heller
Melissa Gardner
LIEFF CABRASER HEIMANN & BERNSTEIN LLP
Defense Counsel
Kristen R Seeger
Kara L McCall
Lawrence P Fogel
Stephanie C Stern
Andrew F Rodheim
SIDLEY AUSTIN LLP
Read About More Class Action Lawsuits & Class Action Settlements:
- CVS lidocaine false advertising $3.8M class action settlement
- Community Surgical Supply data breach class action lawsuit settlement
- AdaptHealth spam texts class action lawsuit settlement
- Advocate Aurora Health pixel tracking $12.2M class action settlement
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Search Keywords
thernos, tharanos, theranose, therenos, theranis, theronos, theranoa, theramos
65 thoughts onTheranos, Walgreens blood testing false ad $45.33M class action lawsuit settlement
Add me
add me
Add me thanks
Please add me to this suit
Add me please
Please add me
Add me please and thank you
Add me please
Add me please